Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03722992 · ClinicalTrials.gov registry record · NA
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
A NA study of Interstitial Cystitis, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03722992: Completed NA study of Interstitial Cystitis, sponsored by TriHealth.
NCT03722992 is a NA study of Interstitial Cystitis that has completed, run by TriHealth. The registered enrollment target is 14 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03722992, a NA study of Interstitial Cystitis, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.
Primary Outcome
Urinary microbiome sequencing analysis will be performed by Resphera Biosciences Laboratory
Conditions Studied
Interventions
- OTHER MBSR
Study Locations (1)
Ohio
- TriHealth - Cincinnati Urogynecology Associates - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-03-07 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
What the finished NCT03722992 record still lists
NCT03722992 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 1 intervention - of which MBSR is the first listed.
NCT03722992 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03722992 about?
NCT03722992 is a clinical study titled "The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients". This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.
What is the current status of trial NCT03722992?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-03-07. Estimated completion is 2020-03-15.
What conditions does trial NCT03722992 study?
This clinical trial studies the following conditions: Interstitial Cystitis.
What interventions are being tested in trial NCT03722992?
The interventions under investigation include: MBSR (OTHER).
Who is sponsoring clinical trial NCT03722992?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03722992 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03722992's enrollment target sits among peer trials
14 24th of 26 higher than 2 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Investigation of PEMF Therapy for Female Patients With IC/BPS
RECRUITING · NA
-
Acupuncture First for IC/BPS
RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy